Respiratory Support and Clinical Outcomes in Critically Ill Patients with COVID-19 in Intensive Care Unit: A Retrospective Study.

Q3 Medicine Tanaffos Pub Date : 2022-04-01
Amir Emami Zeydi, Mohammad Javad Ghazanfari, Sadra Ashrafi, Saman Maroufizadeh, Majid Mashhadban, Tahereh Khaleghdoost Mohammadi, David Darvishnia, Afsaneh Foolady Azarnaminy, Touraj Assadi, Seyed Mostafa Mohsenizadeh, Samad Karkhah
{"title":"Respiratory Support and Clinical Outcomes in Critically Ill Patients with COVID-19 in Intensive Care Unit: A Retrospective Study.","authors":"Amir Emami Zeydi,&nbsp;Mohammad Javad Ghazanfari,&nbsp;Sadra Ashrafi,&nbsp;Saman Maroufizadeh,&nbsp;Majid Mashhadban,&nbsp;Tahereh Khaleghdoost Mohammadi,&nbsp;David Darvishnia,&nbsp;Afsaneh Foolady Azarnaminy,&nbsp;Touraj Assadi,&nbsp;Seyed Mostafa Mohsenizadeh,&nbsp;Samad Karkhah","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Appropriate respiratory support is crucial for improving the clinical outcomes of critically ill patients infected with the SARS-CoV-2 virus. This study aimed to investigate the different modalities of respiratory support and clinical outcomes in patients with COVID-19 in intensive care units (ICUs).</p><p><strong>Materials and methods: </strong>In a retrospective study, we enrolled 290 critically ill COVID-19 patients who were admitted to the ICUs of four hospitals in Mazandaran, northern Iran. Data were extracted from the medical records of all included patients, from December 2019 to July 2021. Patients' demographic data, symptoms, laboratory findings, comorbidities, treatment, and clinical outcomes were collected.</p><p><strong>Results: </strong>46.55% of patients died. Patients with ≥2 comorbidities had significantly increased odds of death (OR=5.88, 95%CI: 1.97-17.52, P=0.001) as compared with patients with no comorbidities. Respiratory support methods such as face mask (survived=37, deceased=18, P=0.022), a non-rebreather mask (survived=39, deceased=12, P<0.001), and synchronized intermittent mandatory ventilation (SIMV) (survived=103, deceased=110, P=0.004) were associated with in-hospital mortality. Duration of respiratory support in nasal cannula (survived=3, deceased=2, P<0.001), face mask (survived=3, deceased=2, P<0.001), a non-rebreather mask (survived=3, deceased=2, P=0.033), mechanical ventilation (survived=5, deceased=6, P<0.019), continuous positive airway pressure (CPAP) (survived=3, deceased=2, P<0.017), and SIMV (survived=4, deceased=5, P=0.001) methods were associated with higher in-hospital mortality.</p><p><strong>Conclusion: </strong>Special attention should be paid to COVID-19 patients with more than two comorbidities. As a specific point of interest, SIMV may increase the in-hospital mortality rate of critically ill patients with COVID-19 connected to mechanical ventilation and be associated with adverse outcomes.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/d0/Tanaffos-21-487.PMC10423861.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tanaffos","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Appropriate respiratory support is crucial for improving the clinical outcomes of critically ill patients infected with the SARS-CoV-2 virus. This study aimed to investigate the different modalities of respiratory support and clinical outcomes in patients with COVID-19 in intensive care units (ICUs).

Materials and methods: In a retrospective study, we enrolled 290 critically ill COVID-19 patients who were admitted to the ICUs of four hospitals in Mazandaran, northern Iran. Data were extracted from the medical records of all included patients, from December 2019 to July 2021. Patients' demographic data, symptoms, laboratory findings, comorbidities, treatment, and clinical outcomes were collected.

Results: 46.55% of patients died. Patients with ≥2 comorbidities had significantly increased odds of death (OR=5.88, 95%CI: 1.97-17.52, P=0.001) as compared with patients with no comorbidities. Respiratory support methods such as face mask (survived=37, deceased=18, P=0.022), a non-rebreather mask (survived=39, deceased=12, P<0.001), and synchronized intermittent mandatory ventilation (SIMV) (survived=103, deceased=110, P=0.004) were associated with in-hospital mortality. Duration of respiratory support in nasal cannula (survived=3, deceased=2, P<0.001), face mask (survived=3, deceased=2, P<0.001), a non-rebreather mask (survived=3, deceased=2, P=0.033), mechanical ventilation (survived=5, deceased=6, P<0.019), continuous positive airway pressure (CPAP) (survived=3, deceased=2, P<0.017), and SIMV (survived=4, deceased=5, P=0.001) methods were associated with higher in-hospital mortality.

Conclusion: Special attention should be paid to COVID-19 patients with more than two comorbidities. As a specific point of interest, SIMV may increase the in-hospital mortality rate of critically ill patients with COVID-19 connected to mechanical ventilation and be associated with adverse outcomes.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症监护病房重症COVID-19患者呼吸支持与临床结局的回顾性研究
背景:适当的呼吸支持是改善SARS-CoV-2病毒感染危重患者临床转归的关键。本研究旨在探讨重症监护病房(icu) COVID-19患者不同方式的呼吸支持和临床结果。材料和方法:在一项回顾性研究中,我们纳入了伊朗北部Mazandaran四家医院重症监护病房的290名COVID-19危重患者。数据提取自2019年12月至2021年7月所有纳入患者的医疗记录。收集患者的人口统计数据、症状、实验室结果、合并症、治疗和临床结果。结果:46.55%的患者死亡。与无合并症的患者相比,有≥2种合并症的患者的死亡几率显著增加(OR=5.88, 95%CI: 1.97-17.52, P=0.001)。呼吸支持方法如口罩(存活37例,死亡18例,P=0.022)、非换气口罩(存活39例,死亡12例)等。结论:对合并两种以上合并症的COVID-19患者应给予特别重视。作为一个特定的兴趣点,SIMV可能会增加与机械通气相关的COVID-19危重患者的住院死亡率,并与不良后果相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tanaffos
Tanaffos Medicine-Critical Care and Intensive Care Medicine
CiteScore
1.10
自引率
0.00%
发文量
0
期刊最新文献
Oncologic Emergencies in Lung Cancer Patients and the Effects of SARS-COV2 Pandemic. Relationship between Underlying Diseases with Morbidity and Mortality in Patients with COVID-19. Status of Inflammatory and Coagulation Factors in COVID-19 and Its Relation with the Disease Severity. Tracheal Lobular Capillary Hemangioma: A Rare Localization. Tracheal Small Cell Carcinoma in a 52-year-old Male: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1